Xinhui Ran

781 total citations · 1 hit paper
20 papers, 484 citations indexed

About

Xinhui Ran is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Xinhui Ran has authored 20 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in Xinhui Ran's work include Lipoproteins and Cardiovascular Health (8 papers), Cancer, Lipids, and Metabolism (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Xinhui Ran is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Cancer, Lipids, and Metabolism (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Xinhui Ran collaborates with scholars based in United States, Australia and Canada. Xinhui Ran's co-authors include Marc S. Sabatine, Michelle L. O’Donoghue, Sabina A. Murphy, Julia Kuder, Norman E. Lepor, Huei Wang, Beat Knüsel, Helina Kassahun, You Wu and J. Antonio G. López and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Xinhui Ran

17 papers receiving 480 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

2022 312 citations Michelle L. O’Donoghue, Robert S. Rosenson et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinhui Ran United States	7	275	122	103	82	55	20	484
Zhu Junren China	2	109 0.4×	117 1.0×	134 1.3×	32 0.4×	28 0.5×	4	392
Johan Gort Netherlands	8	184 0.7×	269 2.2×	125 1.2×	41 0.5×	29 0.5×	8	516
Clara Marquina Australia	14	153 0.6×	81 0.7×	86 0.8×	17 0.2×	32 0.6×	50	491
Roelof A. J. Smit Netherlands	14	116 0.4×	81 0.7×	141 1.4×	21 0.3×	75 1.4×	40	511
S G Baker South Africa	12	302 1.1×	121 1.0×	169 1.6×	128 1.6×	57 1.0×	24	588
Mohammed A. Farooqi Canada	12	62 0.2×	76 0.6×	65 0.6×	47 0.6×	32 0.6×	19	434
Simone Barbieri Italy	12	65 0.2×	146 1.2×	52 0.5×	19 0.2×	70 1.3×	29	457
Fraz Mir United Kingdom	10	131 0.5×	119 1.0×	37 0.4×	13 0.2×	52 0.9×	15	586
Jo Ann E. Manson United States	11	101 0.4×	100 0.8×	147 1.4×	37 0.5×	96 1.7×	15	621
Naomune Yamamoto Japan	14	63 0.2×	149 1.2×	76 0.7×	30 0.4×	75 1.4×	27	496

Countries citing papers authored by Xinhui Ran

Since Specialization

Citations

This map shows the geographic impact of Xinhui Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhui Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhui Ran more than expected).

Fields of papers citing papers by Xinhui Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhui Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhui Ran. The network helps show where Xinhui Ran may publish in the future.

Co-authorship network of co-authors of Xinhui Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhui Ran. A scholar is included among the top collaborators of Xinhui Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhui Ran. Xinhui Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Donoghue, Michelle L., Xinhui Ran, Sabina A. Murphy, et al.. (2025). Long-Term Lipid Lowering With Evolocumab in Older Individuals. Journal of the American College of Cardiology. 85(5). 504–512. 4 indexed citations

Kang, Yu Mi, Robert P. Giugliano, Xinhui Ran, et al.. (2025). Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial. Diabetes Care. 48(9). 1512–1516.

Zimerman, André, Brittany Weber, Xinhui Ran, et al.. (2025). Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial. Circulation. 151(20). 1467–1476. 1 indexed citations

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2024). Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. European Journal of Preventive Cardiology. 31(10). 1216–1223. 8 indexed citations

Zimerman, André, Michelle L. O’Donoghue, Xinhui Ran, et al.. (2024). Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab. NEJM Evidence. 4(1). EVIDoa2400112–EVIDoa2400112. 6 indexed citations

O’Donoghue, Michelle L., Gaetano Maria De Ferrari, Jorge Ferreira, et al.. (2024). Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease. Journal of the American College of Cardiology. 83(6). 652–664. 10 indexed citations

Zimerman, André, Robert P. Giugliano, Xinhui Ran, et al.. (2024). CARDIOVASCULAR BENEFIT OF EVOLOCUMAB IN 27,564 PATIENTS WITH AND WITHOUT AUTOIMMUNE OR INFLAMMATORY DISEASES: AN ANALYSIS OF THE FOURIER TRIAL. Journal of the American College of Cardiology. 83(13). 1682–1682.

O’Donoghue, Michelle L., Xinhui Ran, Sabina A. Murphy, et al.. (2024). LONG-TERM EVOLOCUMAB IN ELDERLY PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: ANALYSIS FROM FOURIER AND FOURIER-OLE. Journal of the American College of Cardiology. 83(13). 2078–2078.

Gildengers, Ariel, Gary P. Stoehr, Xinhui Ran, et al.. (2023). Anticholinergic Drug Burden and Risk of Incident MCI and Dementia. Alzheimer Disease & Associated Disorders. 37(1). 20–27. 3 indexed citations

10.

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2023). Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3. Journal of clinical lipidology. 18(2). e261–e268. 6 indexed citations

11.

Zimerman, André, Michelle L. O’Donoghue, Xinhui Ran, et al.. (2023). Abstract 14714: Long-Term Neurocognitive Safety of LDL-C Lowering With Evolocumab: Open-Label Extension Data From FOURIER. Circulation. 148(Suppl_1). 2 indexed citations

12.

Gildengers, Ariel, et al.. (2023). Benzodiazepine use and risk of incident MCI and dementia in a community sample. International Psychogeriatrics. 36(2). 142–148. 4 indexed citations

13.

O’Donoghue, Michelle L., Robert S. Rosenson, Bariş Gencer, et al.. (2023). ASSOCIATION OF BASELINE LIPOPROTEIN(A) AND PERCENTAGE OF LIPOPROTEIN(A) LOWERING WITH OLPASIRAN. Journal of the American College of Cardiology. 81(8). 1130–1130. 1 indexed citations

14.

Hughes, Tiffany F., Xinhui Ran, Erin Jacobsen, et al.. (2022). Psychosocial implications of early COVID-19 restrictions on older adults in a small-town region in Southwestern, Pennsylvania (USA). International Psychogeriatrics. 36(9). 762–771. 5 indexed citations

15.

O’Donoghue, Michelle L., Robert S. Rosenson, Bariş Gencer, et al.. (2022). Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease. New England Journal of Medicine. 387(20). 1855–1864. 312 indexed citations breakdown →

16.

Sullivan, Kevin, Xinhui Ran, Chung‐Chou H. Chang, et al.. (2021). Ambient fine particulate matter exposure and incident mild cognitive impairment and dementia. Journal of the American Geriatrics Society. 69(8). 2185–2194. 30 indexed citations

17.

Jacobsen, Erin, et al.. (2020). Predictors of attrition in a longitudinal population-based study of aging. International Psychogeriatrics. 33(8). 767–778. 47 indexed citations

18.

Jhamb, Manisha, Xinhui Ran, Hossam Abdalla, et al.. (2020). Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease. Clinical Journal of the American Society of Nephrology. 15(2). 182–190. 30 indexed citations

19.

Tandukar, Srijan, Jonathan G. Yabes, Xinhui Ran, et al.. (2019). Does Kidney Transplantation Affect Sleep and Fatigue in Patients With Kidney Disease?. Transplantation Direct. 5(6). e461–e461. 13 indexed citations

20.

Ran, Xinhui. (2019). Using the dimension reduction method FAMD in the data pre-processing step for risk prediction and for unsupervised clustering. D-Scholarship@Pitt (University of Pittsburgh). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact